These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 16846069

  • 21. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW, Kluft C, Knot EA, de Maat MP, Wilson JH.
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [Abstract] [Full Text] [Related]

  • 22. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR, Gardell SJ.
    Thromb Haemost; 1992 Aug 03; 68(2):165-9. PubMed ID: 1412162
    [Abstract] [Full Text] [Related]

  • 23. Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.
    Tsurupa G, Yakovlev S, McKee P, Medved L.
    Biochemistry; 2010 Sep 07; 49(35):7643-51. PubMed ID: 20687529
    [Abstract] [Full Text] [Related]

  • 24. Comparison of the effects of fibrinogen and fibrin products and isolated peptide chains on the fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator, and on the fibrin-dependent enhancement of the amidolytic activity of one-chain tissue-type plasminogen activator.
    Fischer B.
    Biol Chem Hoppe Seyler; 1990 Nov 07; 371(11):1067-75. PubMed ID: 2128181
    [Abstract] [Full Text] [Related]

  • 25. [Kinetics of glu- and lys-plasminogen activation by the tissue activator in a fibrin clot].
    Makogonenko EM, Kirpa SA, Lugovskoĭ EV, Nazarenko NA, Kudinov SA.
    Biokhimiia; 1987 Oct 07; 52(10):1746-52. PubMed ID: 3122854
    [Abstract] [Full Text] [Related]

  • 26. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
    Lijnen HR, Van Hoef B, Matsuo O, Collen D.
    Biochim Biophys Acta; 1992 Jan 09; 1118(2):144-8. PubMed ID: 1730031
    [Abstract] [Full Text] [Related]

  • 27. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH, Diamond SL.
    J Clin Invest; 1995 Jun 09; 95(6):2483-90. PubMed ID: 7769094
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG, Nguyen KT, Soundar E, Kostousov V, Bomgaars L, Moise A, Hui SK, Teruya J.
    Pediatr Crit Care Med; 2014 Jun 09; 15(5):e198-205. PubMed ID: 24614609
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.